NeoGenomics Announces Six Clinical Data Presentations to be Made at the American Society of Hematology Meeting
NeoGenomics, Inc. (NEO)
Last neogenomics, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.neogenomics.com
Company Research
Source: Marketwire
FORT MYERS, FL -- (Marketwired) -- 12/06/17 -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that its physicians and scientists will present four posters and deliver two oral presentations at the American Society of Hematology's Annual Meeting. The presentations will highlight NeoGenomics' experience with liquid biopsy testing, and characterization of mutational profiles in the context of hematological disease clonal evolution and progression. The analyses were done using novel approaches to analyze cell-free DNA/RNA and variant allele frequency. The diseases to be discussed include Myelodysplastic Syndrome, Clonal Hematopoiesis of Indeterminate Potential (CHIP), and Acute Myeloid Leukemia. NeoGenomics Chairman and CEO, Douglas VanOort, said "NeoGenomics' commitment to medical and scientific research and development is evidenced by our team's presentations at this year's American Society of Hematology
Show less
Read more
Impact Snapshot
Event Time:
NEO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NEO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NEO alerts
High impacting NeoGenomics, Inc. news events
Weekly update
A roundup of the hottest topics
NEO
News
- NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024Business Wire
- NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting [Yahoo! Finance]Yahoo! Finance
- NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual MeetingBusiness Wire
- All You Need to Know About NeoGenomics (NEO) Rating Upgrade to Buy [Yahoo! Finance]Yahoo! Finance
- NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report [Yahoo! Finance]Yahoo! Finance
NEO
Earnings
- 2/20/24 - Beat
NEO
Sec Filings
- 4/8/24 - Form ARS
- 4/8/24 - Form DEFA14A
- 4/8/24 - Form DEF
- NEO's page on the SEC website